Valbiotis SA (EPA:ALVAL)
France · Delayed Price · Currency is EUR 0.8200
-0.0100 (-1.20%)
Nov 20, 2025, 5:35 PM CET
Valbiotis Revenue
Valbiotis had revenue of 333.00K EUR in the half year ending June 30, 2025, a decrease of -92.15%. This brings the company's revenue in the last twelve months to 474.00K, down -10.06% year-over-year. In the year 2024, Valbiotis had annual revenue of 176.00K, down -96.28%.
Revenue (ttm)
474.00K
Revenue Growth
-10.06%
P/S Ratio
40.92
Revenue / Employee
10.77K
Employees
44
Market Cap
19.40M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 176.00K | -4.56M | -96.28% |
| Dec 31, 2023 | 4.73M | 3.95M | 502.93% |
| Dec 31, 2022 | 785.00K | 487.00K | 163.42% |
| Dec 31, 2021 | 298.00K | -2.79M | -90.36% |
| Dec 31, 2020 | 3.09M | 3.00M | 3,297.80% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sanofi | 45.93B |
| EssilorLuxottica Société anonyme | 27.24B |
| Eurofins Scientific SE | 7.14B |
| emeis Société anonyme | 5.77B |
| Clariane SE | 5.31B |
| bioMérieux | 4.12B |
| Ipsen | 3.76B |
| Sartorius Stedim Biotech | 2.95B |